Evidence map›Paper›PMID 32500165›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2021

Causes of death after treatment of small coronary artery disease with paclitaxel-coated balloons.

Raban V Jeger, Christoph Kaiser, Norman Mangner, Franz X Kleber, Bruno Scheller, BASKET-SMALL 2 Investigators

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease in elective clinical practice.Clinical research in cardiology : official journal of the German Cardiac Society · 2023
    Article
  3. Efficacy and safety of drug-coated balloons according to coronary vessel size. A report from the BASKET-SMALL 2 trial.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2022
    Article
  4. Coronary Drug-Coated Balloons for De Novo and In-Stent Restenosis Indications.Journal of the Society for Cardiovascular Angiography & Interventions
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Raban V JegerUniversity Hospital Basel, University of Basel, Basel, Switzerland. raban.jeger@usb.ch.ORCID 0000-0003-1290-5491
Christoph KaiserUniversity Hospital Basel, University of Basel, Basel, Switzerland.
Norman MangnerHeart Center Dresden at the Technical University of Dresden, Dresden, Germany.
Franz X KleberPaul Gerhardt Stift, Wittenberg, Germany.
Bruno SchellerClinical and Experimental Interventional Cardiology, University of Saarland, Homburg/Saar, Germany.
BASKET-SMALL 2 Investigators

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 32003B_135547
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Coated Materials, BiocompatibleAdultAgedAged, 80 and overAngioplasty, Balloon, CoronaryAntineoplastic Agents, PhytogenicCause of DeathCoronary Artery DiseaseFemaleHumansMaleMiddle AgedPaclitaxelPostoperative PeriodSwitzerlandAntineoplastic Agents, PhytogenicCoated Materials, BiocompatiblePaclitaxel

Identifiers

PMID32500165

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.